To the relief of patients diagnosed with hepatitis C, the U.S. Food and Drug Administration approved two new treatments late last year, and a few more are on the way.
Now scientists are solving another side of the disease’s problem: identifying the millions more who have the virus but don’t know it — and unwittingly pass it on. A report in the ACS journal Analytical Chemistry describes a novel, scrapbook-inspired test that does just that.
Xuan Mu, Zhi Zheng and colleagues point out that the hepatitis C virus (HCV), a blood-borne pathogen that can cause liver cirrhosis, cancer and even death, kills more people in the U.S. than HIV. It also infects an estimated 150 million people around the world. Although diagnostic tests exist, they require an initial screening and then a costly second test for confirmation. The extra office visits, money and time required for a definitive diagnosis means a lot of people simply can’t or won’t follow up. To make diagnosis more accessible, the researchers took advantage of the recent development of new, inexpensive paper-based medical technologies and applied it to HCV screening.
Taking a page from the popular scrapbooking pastime, the scientists used a flower-shaped metal paper cutter to punch out shapes from special paper for their diagnostic test. The method solves the problem of patterning the paper, made of nitrocellulose — a highly flammable substance — without using heat. They add antigens, antibodies and other chemicals to the paper to test patient samples. With one flower-shaped paper, they can conduct both HCV tests on a sample simultaneously in just minutes, instead of hours.
The Latest on: Paper-based diagnostics
[google_news title=”” keyword=”Paper-based diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Paper-based diagnostics
- 16 Surprising Ways AI Enhances Healthcare Diagnostics And Deliveryon May 1, 2024 at 10:14 am
Many patients might be surprised to learn just how big an impact AI is poised to make in modern healthcare delivery.
- Quest Diagnostics carves out PathAI’s digital pathology lab, plots AI ramp upon May 1, 2024 at 7:30 am
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multi-layered deal with PathAI—acquiring some assets, licensing out others. | Quest ...
- MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMedon May 1, 2024 at 4:47 am
MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the first quarter ended March 31, 2024 and the ...
- Machine Learning and Neural Network Can Be Effective Diagnostic Tools in MDS, Study Findson April 30, 2024 at 12:51 pm
The investigators said their new system makes it possible for researchers to leverage artificial intelligence even if they do not have expertise working with advanced software.
- Google’s Med-Gemini Model Achieves 91.1% Accuracy in Medical Diagnosticson April 30, 2024 at 12:06 pm
Google and DeepMind's latest model excels in multimodal medical dialogues with diagnostic precision. The model has surpassed existing benchmarks.
- Biotricity Expands Market Reach to Pulmonary and Neurology Fields Through Latest Partnerships with Two Leading Home-Based Diagnostic Companieson April 30, 2024 at 6:06 am
REDWOOD CITY, CA / ACCESSWIRE / April 30, 2024 / Biotricity Inc. (NASDAQ:BTCY), a groundbreaking Technology-as-a-Service (TaaS) company committed to delivering cutting-edge medical and consumer ...
- Owlstone Medical's $6.5M funding from investors and Bill and Melinda Gates Foundationon April 29, 2024 at 7:35 pm
Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine, has announced a funding to the tune of $6.5 million.
- Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annuallyon April 29, 2024 at 5:33 am
Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in the next generation of precision cardiovascular medicine technologies that combine proprietary AI algorithms with epigenetic and genetic ...
- How AI-Driven Diagnostics Can Save Lives When Humans Can’ton April 28, 2024 at 8:48 pm
AI offers promise in improving diagnostics, detecting conditions faster and more accurately than humans. It can alleviate staff workload and improve health outcomes ...
- New sustainable diagnostic approach offers precision cancer testing with minimal environmental impacton April 24, 2024 at 3:51 am
In a recent study in Nature Sustainability, researchers describe a diagnostic approach that combines dried sera spots (DSS) with nanoparticle-enhanced laser desorption and ionization mass ...
via Bing News